Trial
NCT05209984
A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Eurofarma Laboratorios S.A.
Collaborators
—
Condition
Overweight
Intervention
ADF1 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 75mg
Why stopped
Strategic change in development priorities
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-18